ArticleThe oncologist2025

Evaluating Food and Drug Administration approved gastrointestinal cancer drugs: clinical benefit and trial endpoints over the past two decades.

Fares Jamal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.